Drug Shortage Report for BUTRANS 20
Report ID | 183517 |
Drug Identification Number | 02341220 |
Brand name | BUTRANS 20 |
Common or Proper name | Buprenorphine Transdermal System |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | BUPRENORPHINE |
Strength(s) | 20MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 4 |
ATC code | N02AE |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-02-03 |
Actual start date | 2023-02-03 |
Estimated end date | 2023-03-10 |
Actual end date | 2023-02-08 |
Shortage status | Resolved |
Updated date | 2023-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-02-09 | French | Compare |
v2 | 2023-02-09 | English | Compare |
v1 | 2023-02-03 | English | Compare |
Showing 1 to 3 of 3